Additionally, an existing protocol for systematic reviews examining objective sleep measures as indicators of dementia (Antonioni et al., 2025), and ongoing clinical trials focused on how obstructive sleep apnea influences amyloid and tau burden (Malhotra, 2024), further underscore the relevance of sleep to AD pathophysiology. Here, MAPT is linked to Alzheimer disease.